Tenor Capital Management »

Biomarin Pharma Inc convertible/ shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $24B 24M 998.10
2024-03-31 $21B 22M 984.50
2023-12-31 $2.9B 2.9M 988.09

More positions owned by Tenor Capital Management

Insight Enterprises Note 0.750% 2/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Cyberark Software Note 11/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Hubspot Note 0.375% 6/0 (Principal)
Natera Note 2.250% 5/0 (Principal)
Liberty Media Corp Note 2.750% 12/0 (Principal)
Ati Note 3.500% 6/1 (Principal)
Ringcentral Note 3/1 (Principal)
Chart Inds Note 1.000%11/1 (Principal)
Nuvasive Note 0.375% 3/1 (Principal)
Livongo Health Note 0.875% 6/0 (Principal)
Omnicell Note 0.250% 9/1 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Five9 Note 0.500% 6/0 (Principal)

View all positions for Tenor Capital Management

Top funds holding Biomarin Pharma Inc convertible/

Osterweis Capital Management
OZ Management
Millennium Management
Lazard Asset Management
Glazer Capital
Citigroup
Aviva
Tenor Capital Management
Piper Jaffray & Co.
Partner Fund Management
Jpmorgan Chase & Co
State Street Corporation
Branch Banking & Trust Company
Kohlberg Kravis Roberts & Co
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/